Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
GenomeFrontier Therapeutics TW Co., Ltd.
Pell Bio-Med Technology Co., Ltd.
Ruijin Hospital
Florida International University
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Columbia University
Mayo Clinic
Children's Oncology Group
SWOG Cancer Research Network
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)